NLRP8

gene
On this page

Also known as NOD16PAN4CLR19.2

Summary

NLRP8 (NLR family pyrin domain containing 8, HGNC:22940) is a protein-coding gene on chromosome 19q13.43, encoding NACHT, LRR and PYD domains-containing protein 8 (Q86W28). Involved in inflammation.

This gene encodes a member of the nucleotide-binding oligomerization domain/ leucine rich repeat/ pyrin domain containing (NLRP) subfamily, which belongs to the Nod-like receptor family of proteins. NLRP genes play roles in the mammalian innate immune system through inflammasome formation and activation of caspases. In addition, NLRP genes have been found to function during mammalian reproduction. Consistent with a function during human preimplantation development, this gene is expressed at high levels in oocytes with decreased levels in embryos. Alternative splicing results in multiple transcript variants.

Source: NCBI Gene 126205 — RefSeq curated summary.

At a glance

  • GWAS associations: 3
  • Clinical variants (ClinVar): 198 total
  • MANE Select transcript: NM_001433706

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:22940
Approved symbolNLRP8
NameNLR family pyrin domain containing 8
Location19q13.43
Locus typegene with protein product
StatusApproved
AliasesNOD16, PAN4, CLR19.2
Ensembl geneENSG00000179709
Ensembl biotypeprotein_coding
OMIM609659
Entrez126205

Gene structure

Transcript identifiers

Ensembl transcripts: 3 — 3 protein_coding

ENST00000291971, ENST00000590542, ENST00000850972

RefSeq mRNA: 2 — MANE Select: NM_001433706 NM_001317000, NM_001433706

CCDS: CCDS12937, CCDS82402

Canonical transcript exons

ENST00000850972 — 10 exons

ExonStartEnd
ENSE000011784475597365255973822
ENSE000011784595597613355976303
ENSE000012437685597939455979564
ENSE000012437855597054455970696
ENSE000012437935596621355966380
ENSE000012438005595450155956100
ENSE000012438055595253855952612
ENSE000012438265594783255948269
ENSE000013287165596206755962237
ENSE000042830985598105955981158

Expression profiles

Bgee: expression breadth tissue_specific, 3 present calls, max score 90.47.

Top tissues by expression

239 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
secondary oocyteCL:000065590.47gold quality
oocyteCL:000002375.61silver quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047373.99gold quality
amniotic fluidUBERON:000017360.24gold quality
epithelium of nasopharynxUBERON:000195158.66gold quality
ventral tegmental areaUBERON:000269156.11gold quality
mammary ductUBERON:000176555.60gold quality
buccal mucosa cellCL:000233655.57silver quality
jejunumUBERON:000211555.43gold quality
inferior vagus X ganglionUBERON:000536354.20gold quality
subthalamic nucleusUBERON:000190653.96gold quality
jejunal mucosaUBERON:000039953.44gold quality
gingival epitheliumUBERON:000194953.20gold quality
dorsal plus ventral thalamusUBERON:000189752.85gold quality
layer of synovial tissueUBERON:000761652.39gold quality
dorsal root ganglionUBERON:000004452.24gold quality
saphenous veinUBERON:000731852.24gold quality
pericardiumUBERON:000240752.17gold quality
substantia nigra pars reticulataUBERON:000196652.14gold quality
tongueUBERON:000172352.13gold quality
medulla oblongataUBERON:000189652.13gold quality
penisUBERON:000098952.06gold quality
nippleUBERON:000203052.00gold quality
synovial jointUBERON:000221752.00gold quality
thymusUBERON:000237052.00gold quality
pharyngeal mucosaUBERON:000035551.87gold quality
tracheaUBERON:000312651.85gold quality
pylorusUBERON:000116651.82gold quality
renal medullaUBERON:000036251.80gold quality
body of tongueUBERON:001187651.75gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes5.27

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

30 targeting NLRP8, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-190A-3P100.0080.355520
HSA-MIR-5011-5P100.0083.465820
HSA-MIR-8485100.0077.574731
HSA-MIR-4262100.0073.263931
HSA-MIR-4481100.0066.421669
HSA-MIR-511-3P99.9968.851467
HSA-MIR-485-3P99.9870.681585
HSA-MIR-539-3P99.9870.741616
HSA-MIR-569699.9872.364487
HSA-MIR-7845-5P99.8864.88771
HSA-MIR-394199.8670.542735
HSA-MIR-4659A-3P99.8072.624248
HSA-MIR-4659B-3P99.8072.624248
HSA-MIR-548M99.7068.871749
HSA-MIR-580-3P99.6769.231841
HSA-MIR-570099.6469.882280
HSA-MIR-568999.5071.261154
HSA-MIR-330-3P99.4169.952521
HSA-MIR-425199.4069.193363
HSA-MIR-504-3P99.3067.181745
HSA-MIR-7854-3P99.0866.261117
HSA-MIR-6831-5P98.2667.20990
HSA-MIR-569198.2367.021335
HSA-MIR-6805-3P98.2367.021334
HSA-MIR-442197.9964.89701
HSA-MIR-5699-3P97.8165.00861
HSA-MIR-3927-3P97.6866.76892
HSA-MIR-6791-3P97.4564.311123
HSA-MIR-6829-3P97.4564.311137
HSA-MIR-526B-5P97.4167.991074

Cross-species orthologs

0 orthologs

Paralogs (20): NLRP2 (ENSG00000022556), NLRP1 (ENSG00000091592), NOD1 (ENSG00000106100), NLRC5 (ENSG00000140853), NLRP12 (ENSG00000142405), NLRP14 (ENSG00000158077), NLRP4 (ENSG00000160505), NLRX1 (ENSG00000160703), NLRP3 (ENSG00000162711), NOD2 (ENSG00000167207), NLRP7 (ENSG00000167634), NLRC3 (ENSG00000167984), NLRP5 (ENSG00000171487), NLRP13 (ENSG00000173572), NLRP6 (ENSG00000174885), CIITA (ENSG00000179583), NLRP11 (ENSG00000179873), NLRP10 (ENSG00000182261), NLRP9 (ENSG00000185792), PYDC2 (ENSG00000253548)

Protein

Protein identifiers

NACHT, LRR and PYD domains-containing protein 8Q86W28 (reviewed: Q86W28)

Alternative names: Nucleotide-binding oligomerization domain protein 16, PYRIN and NACHT-containing protein 4

All UniProt accessions (1): Q86W28

UniProt curated annotations — full annotation on UniProt →

Function. Involved in inflammation.

Subcellular location. Cytoplasm.

Similarity. Belongs to the NLRP family.

Isoforms (2)

UniProt IDNamesCanonical?
Q86W28-11yes
Q86W28-22

RefSeq proteins (2): NP_001303929, NP_001420635* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR001611Leu-rich_rptRepeat
IPR004020DAPINDomain
IPR007111NACHT_NTPaseDomain
IPR011029DEATH-like_dom_sfHomologous_superfamily
IPR027417P-loop_NTPaseHomologous_superfamily
IPR032675LRR_dom_sfHomologous_superfamily
IPR041075NOD1/2_WHDomain
IPR041267NLRP_HD2Domain
IPR050637NLRP_innate_immun_regFamily

Pfam: PF02758, PF05729, PF13516, PF17776, PF17779

UniProt features (25 total): sequence variant 12, repeat 5, domain 2, region of interest 2, chain 1, compositionally biased region 1, binding site 1, splice variant 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q86W28-F180.260.40

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Ligand- & substrate-binding residues (1): 210–217

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 28 (showing top): GOBP_INFLAMMATORY_RESPONSE, HATADA_METHYLATED_IN_LUNG_CANCER_DN, GOBP_REGULATION_OF_RESPONSE_TO_STRESS, GOBP_REGULATION_OF_RESPONSE_TO_EXTERNAL_STIMULUS, GOBP_REGULATION_OF_INFLAMMATORY_RESPONSE, GOBP_REGULATION_OF_DEFENSE_RESPONSE, GOMF_ADENYL_NUCLEOTIDE_BINDING, LU_EZH2_TARGETS_DN, SRC_UP.V1_DN, ZNF146_TARGET_GENES, MIR8485, MIR4659A_3P_MIR4659B_3P, MIR5700, MIR7854_3P, JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_UP

GO Biological Process (1): regulation of inflammatory response (GO:0050727)

GO Molecular Function (3): ATP binding (GO:0005524), nucleotide binding (GO:0000166), protein binding (GO:0005515)

GO Cellular Component (1): cytoplasm (GO:0005737)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
inflammatory response1
regulation of defense response1
regulation of response to external stimulus1
adenyl ribonucleotide binding1
purine ribonucleoside triphosphate binding1
nucleoside phosphate binding1
heterocyclic compound binding1
binding1
intracellular anatomical structure1
cellular anatomical structure1

Protein interactions and networks

STRING

338 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
NLRP8MEFVO15553744
NLRP8CASP1P29466585
NLRP8OR10P1Q8NGE3460
NLRP8NLRC4Q9NPP4396
NLRP8NAIPQ13075384
NLRP8IFNGR2P38484371
NLRP8IFNGR1P15260360
NLRP8ZNF804BA4D1E1323
NLRP8CARD19Q96LW7320
NLRP8ZSCAN5BA6NJL1308
NLRP8TRIM5Q9C035306
NLRP8NLRP1Q9C000293
NLRP8POTECB2RU33290
NLRP8ZSCAN5AQ9BUG6290
NLRP8CARD8Q9Y2G2289

IntAct

2 interactions, top by confidence:

ABTypeScore
NLRP8DNAJB5psi-mi:“MI:0914”(association)0.350

BioGRID (3): DNAJB5 (Affinity Capture-MS), DNAJB4 (Affinity Capture-MS), NLRP8 (Affinity Capture-MS)

ESM2 similar proteins: A0A0G2JMD5, A1Z198, A3QJZ6, A3QJZ7, A6NGN4, D9I2F9, D9I2G1, D9I2G3, D9I2G4, D9I2H0, E9Q5G7, H0Y7S4, O60809, O60810, O60811, O60813, O95521, O95522, P0DUQ1, P0DUQ2, P78395, Q0GKD5, Q288C4, Q2LKU9, Q2LKV5, Q2LKW6, Q3TKR3, Q3UWY1, Q5SWL7, Q5SWL8, Q5TYX0, Q5VT98, Q5VTA0, Q5VWM3, Q5VWM4, Q5VWM6, Q5VXH4, Q5VXH5, Q66X05, Q66X19

Diamond homologs: A0A386CAB9, A1Z198, A6QLE5, B0FPE9, D4A523, D9I2F9, D9I2G1, D9I2G3, D9I2G4, D9I2H0, E9Q5R7, O15553, P10775, P13489, P29315, P59044, P59045, P59046, Q0GKD5, Q288C4, Q2LKU9, Q2LKV2, Q2LKV5, Q2LKW6, Q3TKR3, Q63035, Q647I9, Q66X01, Q66X03, Q66X19, Q6B966, Q7RTR0, Q86W24, Q86W25, Q86W26, Q86W28, Q8BU40, Q8C6J9, Q8CCN1, Q8HZP9

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

198 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance162
Likely benign12
Benign1

Top pathogenic / likely-pathogenic (0)

SpliceAI

2095 predictions. Top by Δscore:

VariantEffectΔscore
19:55956099:GA:Gdonor_gain1.0000
19:55956101:G:GGdonor_gain1.0000
19:55962062:T:Gacceptor_gain1.0000
19:55976301:GGA:Gdonor_gain1.0000
19:55976302:GA:Gdonor_gain1.0000
19:55976302:GAG:Gdonor_gain1.0000
19:55976304:G:GGdonor_gain1.0000
19:55979384:T:Aacceptor_gain1.0000
19:55979565:G:GGdonor_gain1.0000
19:55981135:A:Gdonor_gain1.0000
19:55981144:G:GTdonor_gain1.0000
19:55948234:A:AGdonor_gain0.9900
19:55948268:TGGT:Tdonor_loss0.9900
19:55948269:GGT:Gdonor_loss0.9900
19:55948270:G:GCdonor_loss0.9900
19:55952537:GCC:Gacceptor_gain0.9900
19:55954494:A:Gacceptor_gain0.9900
19:55954496:TCTA:Tacceptor_loss0.9900
19:55954497:CTAG:Cacceptor_loss0.9900
19:55954498:TA:Tacceptor_loss0.9900
19:55954499:AGGTA:Aacceptor_loss0.9900
19:55956094:GCTC:Gdonor_gain0.9900
19:55962061:A:AGacceptor_gain0.9900
19:55962065:A:AGacceptor_gain0.9900
19:55962066:G:GGacceptor_gain0.9900
19:55962066:GAGC:Gacceptor_gain0.9900
19:55962238:G:GGdonor_gain0.9900
19:55966062:A:AGacceptor_gain0.9900
19:55970697:G:GGdonor_gain0.9900
19:55976131:A:AGacceptor_gain0.9900

AlphaMissense

0 scored. Top likely-pathogenic:

dbSNP variants (sampled 300 via entrez): RS1000114054 (19:55947819 T>A,C), RS1000165016 (19:55957579 G>A), RS1000221030 (19:55988628 G>A,C), RS1000225217 (19:55960534 A>G), RS1000244011 (19:55955135 G>A), RS1000297570 (19:55964113 G>A), RS1000359931 (19:55965091 G>T), RS1000385244 (19:55984525 A>G), RS1000453341 (19:55945845 G>A), RS1000646996 (19:55985079 G>A), RS1000790236 (19:55968036 A>G), RS1000816140 (19:55950688 G>A), RS1000831151 (19:55960217 G>A), RS1000837781 (19:55984728 T>C,G), RS1000921132 (19:55979011 C>T)

Disease associations

OMIM: gene MIM:609659 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

3 associations (top):

StudyTraitp-value
GCST001538_32Immune reponse to smallpox (secreted IFN-alpha)5.000000e-07
GCST001762_317Obesity-related traits8.000000e-06
GCST010206_11Anorectal malformation8.000000e-11

EFO canonical traits (3, from GWAS)

EFO IDTrait name
EFO:0004645response to vaccine
EFO:0004873cytokine measurement
EFO:0003940physical activity

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

PharmGKB variants

1 variants.

VariantGenesLevelScore#Clin annotsDrugs
rs306468NLRP80.000

GtoPdb / IUPHAR curated pharmacology

(IUPHAR/BPS Guide to Pharmacology — expert-curated)

Target class: catalytic receptor — NOD-like receptor family

CTD chemical–gene interactions

9 total (human), top 9 by PubMed support.

ChemicalActions (top 5)PubMed papers
Benzo(a)pyreneaffects methylation, decreases methylation2
benzo(e)pyreneincreases methylation1
CGP 52608affects binding, increases reaction1
erucylphospho-N,N,N-trimethylpropylammoniumincreases expression1
bisphenol Sincreases methylation1
Hydrogen Peroxideaffects expression1
Methapyrileneincreases methylation1
Aflatoxin B1decreases methylation1
Asbestos, Crocidolitedecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

  • Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): anorectal malformation